However, in an in vivo study in gastric cancer ICAM-1 is indicated as a possible inhibitor of peritoneal metastasis due to ICAM-1/lymphocyte function-associated antigen 1 (LFA1)-mediated mononuclear cell recruitment [111]. This evidence concerns the gene ICAM1 and gastric cancer.